NEW YORK, April 9, 2014 /PRNewswire/ --
Today, Analysts Review released its analysts' notes regarding
Caterpillar Inc. (NYSE: CAT), Northrop Grumman Corporation (NYSE:
NOC), Emerson Electric Co. (NYSE: EMR), Martin Marietta Materials
Inc. (NYSE: MLM), and Danaher Corporation (NYSE: DHR). Private
wealth members receive these notes ahead of publication. To reserve
complementary membership, limited openings are available at:
http://www.AnalystsReview.com/register
--
Caterpillar Inc. Analyst Notes
Caterpillar Inc. (Caterpillar) posted on its Events Calendar
section of the Company's website that it will release its Q1 2014
financial results on April 24, 2014.
According to Zacks Investment research data, the consensus EPS
forecast for Q1 2014 is $1.25. The
Peoria, Illinois-based Company
posted a stronger-than-expected Q4 2013 profit as cost
rationalization and rise in demand for its building equipment
offset continued weak sales to the mining industry. For Q4 2013,
the Company reported a profit per share of $1.54. Analysts, on average, expected Caterpillar
to post a profit of $1.28 a share on,
according to Thomson Reuters estimates. The full analyst notes on
Caterpillar Inc. are available to download free of charge at:
http://www.AnalystsReview.com/04092014/CAT/report.pdf
--
Northrop Grumman Corporation Analyst Notes
On April 3, 2014, Northrop Grumman
Corporation (Northrop Grumman) along with the U.S. Air Force
partners announced the completion of a series of ground and air
demonstrations of the U.S. Air Force RQ-4 Global Hawk unmanned
aircraft system (UAS) at Beale Air Force Base, California. The demonstrations expanded the
adaptability of the Global Hawk system to use an additional
Satellite Communications (SATCOM) link to improve the transfer of
mission data. According to the Company, the above said exercise
took place between January 13 - 15,
2014 that highlighted the unique split link capability for
Global Hawk that allows it to send mission data through a satellite
link that is independent of the link used for command and control.
The full analyst notes on Northrop Grumman Corporation are
available to download free of charge at:
http://www.AnalystsReview.com/04092014/NOC/report.pdf
--
Emerson Electric Co. Analyst Notes
Emerson Electric Co. (Emerson) posted on the Events Section of
the Company's website that it plans to release its Q2 FY 2014
financial results (period ended March 31,
2014) on May 6, 2014. The
earnings release will be followed by a conference call at
2:00 p.m. ET to discuss the results.
According to Zacks Investment research data, the consensus EPS
forecast for Q2 FY 2014 is $0.85.
Excluding $0.02 of acquisition costs,
the Company reported EPS of $0.67 for
Q1 FY 2014, which was in line with the expectations of analysts
polled by Thomson Reuters. Excluding impairments and repatriation
charges in the prior year, FY 2014 EPS is expected to increase
4%-7%, or 33%-38% on a reported basis, the Company said in its Q1
FY 2014 earnings release. The full analyst notes on Emerson
Electric Co. are available to download free of charge at:
http://www.AnalystsReview.com/04092014/EMR/report.pdf
--
Martin Marietta Materials Inc. Analyst Notes
On April 4, 2014, Martin Marietta
Materials Inc.'s (Martin Marietta)
stock moved up 2.41% to end the trading session at $127.70, outperforming the S&P 500 which lost
1.25%. Martin Marietta's stock
opened the session at $124.77 and
oscillated in the range of $124.77 -
$130.00 thereby, creating a 52-week high of $130.00. A total of 1.65 million shares were
traded, which was above its 30-day average trading volume of 0.63
million. Over the past three months, the stock has gained 28.50%
outperforming the S&P 500 Index, which returned 1.84% during
the same period. The full analyst notes on Martin Marietta
Materials Inc. are available to download free of charge at:
http://www.AnalystsReview.com/04092014/MLM/report.pdf
--
Danaher Corporation Analyst Notes
On April 4, 2014, Danaher
Corporation (Danaher) announced that the Company has revised the
timing of its Q1 2014 earnings conference call that it scheduled on
April 17, 2014. The conference call
will now begin at 7:30 a.m. EDT and
will last approximately one hour. According to Zacks Investment
research data, the consensus EPS forecast for Q1 2014 is
$0.80. Danaher designs, manufactures
and markets professional, medical, industrial and commercial
products and services in the sectors of test and measurement,
environmental, life sciences, dental, and industrial technologies.
The full analyst notes on Danaher Corporation are available to
download free of charge at:
http://www.AnalystsReview.com/04092014/DHR/report.pdf
--
About Analysts Review
We provide our members with a simple and reliable way to leverage
our economy of scale. Most investors do not have time to track all
publicly traded companies, much less perform an in-depth review and
analysis of the complexities contained in each situation. That's
where Analysts Review comes in. We provide a single unified
platform for investors' to hear about what matters. Situation
alerts, moving events, and upcoming opportunities.
--
=============
EDITOR NOTES:
- This is not company news. We are an independent source and our
views do not reflect the companies mentioned.
- Information in this release is fact checked and produced on a
best efforts basis and reviewed by Ananya
Ghosh, a CFA charterholder. However, we are only human and
are prone to make mistakes. If you notice any errors or omissions,
please notify us below.
- This information is submitted as a net-positive to companies
mentioned, to increase awareness for mentioned companies to our
subscriber base and the investing public.
- If you wish to have your company covered in more detail by our
team, or wish to learn more about our services, please contact us
at pubco [at] AnalystsReview.com.
- For any urgent concerns or inquiries, please contact us
at compliance [at] AnalystsReview.com.
- Are you a public company? Would you like to see similar
coverage on your company? Send us a full investors' package to
research [at] AnalystsReview.com for consideration.
COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort
basis. This document, article or report is prepared and authored by
Analysts Review. An outsourced research services provider
represented by Ananya Ghosh, CFA,
has only reviewed the information provided by Analysts Review in
this article or report according to the Procedures outlined by
Analysts Review. Analysts Review is not entitled to veto or
interfere in the application of such procedures by the outsourced
provider to the articles, documents or reports, as the case may
be.
NOT FINANCIAL ADVICE
Analysts Review makes no warranty, expressed or implied, as to
the accuracy or completeness or fitness for a purpose (investment
or otherwise), of the information provided in this document. This
information is not to be construed as personal financial advice.
Readers are encouraged to consult their personal financial advisor
before making any decisions to buy, sell or hold any securities
mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED
Analysts Review is not responsible for any error which may be
occasioned at the time of printing of this document or any error,
mistake or shortcoming. No liability is accepted by Analysts Review
whatsoever for any direct, indirect or consequential loss arising
from the use of this document. Analysts Review expressly disclaims
any fiduciary responsibility or liability for any consequences,
financial or otherwise arising from any reliance placed on the
information in this document. Analysts Review does not (1)
guarantee the accuracy, timeliness, completeness or correct
sequencing of the information, or (2) warrant any results from use
of the information. The included information is subject to change
without notice.
CFA® and Chartered Financial Analyst® are registered trademarks
owned by CFA Institute.
SOURCE Analysts Review